Soleno Therapeutics, Inc. (6XC.F)
Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
At close: 03:29PM CEST
| Previous Close | 38.38 |
| Open | 37.32 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's Range | 37.32 - 37.48 |
| 52 Week Range | 3.43 - 48.40 |
| Volume | |
| Avg. Volume | 0 |
| Market Cap | 1.417B |
| Beta (5Y Monthly) | -1.40 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Simply Wall St.
While institutions invested in Soleno Therapeutics, Inc. (NASDAQ:SLNO) benefited from last week's 4.8% gain, private equity firms stood to gain the most
Key Insights Significant control over Soleno Therapeutics by private equity firms implies that the general public has...
- GuruFocus.com
CEO Bhatnagar Anish Sells 18,980 Shares of Soleno Therapeutics Inc (SLNO)
Soleno Therapeutics Inc (NASDAQ:SLNO), a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases.
- GuruFocus.com
Insider Sell: CFO James Mackaness Sells 5,175 Shares of Soleno Therapeutics Inc (SLNO)
Soleno Therapeutics Inc (NASDAQ:SLNO), a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases.
© 2024 Yahoo. All rights reserved.